NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes
- PMID: 17547834
- DOI: 10.1007/s11892-007-0029-z
NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes
Abstract
The risk of chronic liver disease and liver-related mortality is increased in patients with type 2 diabetes mellitus. Several cohort studies have suggested a metabolic pathway from nonalcoholic fatty liver, nonalcoholic steatohepatitis, cryptogenic cirrhosis, and eventually hepatocellular carcinoma. Although cardiovascular risk remains the major cause for excess mortality in type 2 diabetes mellitus, the risk of progressive liver disease should no longer be underscored.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
